Results 221 to 230 of about 4,744,541 (408)

Anti‐seizure medications in patients with post‐stroke epilepsy: A survival analysis study

open access: yesEpilepsia, EarlyView.
Abstract Objective The role of antiseizure medications (ASMs) in patients with post‐stroke epilepsy (PSE) is still debated. Although a few studies have compared the efficacy of different ASMs on mortality in patients with PSE, overall evidence on the impact of ASM use on survival is limited.
Ippazio Cosimo Antonazzo   +9 more
wiley   +1 more source

Persistent headache after aneurysmal subarachnoid hemorrhage: Prevalence, characteristics, and migraine history as a prognostic factor

open access: yesHeadache: The Journal of Head and Face Pain, EarlyView.
Abstract Objectives/Background Persistent headache (PH) after an aneurysmal subarachnoid hemorrhage (aSAH) and the influence of migraine history (MH) on its evolution and prognosis is poorly understood. Our study aims are to (1) determine the prevalence, characteristics, and prognostic factors of PH after aSAH; and (2) study the impact of personal MH ...
Laura Gómez‐Dabó   +9 more
wiley   +1 more source

Symptomatic Deep Venous Thrombosis of the Upper Extremity Following Transvenous Lead Extraction, Data From EXTRACT Registry

open access: yesJournal of Cardiovascular Electrophysiology, EarlyView.
ABSTRACT Background Venous thrombosis occurring after TLE procedures is a fairly common but poorly described complication and requires further investigation into its causes. Aim The aim of this study was to identify independent predictors of UEDVT occurrence after TLE procedures.
Michal Joniec   +9 more
wiley   +1 more source

Association of Post-procedural Glucose with Clinical Outcomes After Endovascular Therapy for Large Vessel Occlusion. [PDF]

open access: yesNeurol Ther
Fu J   +9 more
europepmc   +1 more source

Clinical outcomes of endovascular therapy for aortoiliac artery chronic total occlusion via the transradial approach. [PDF]

open access: yesCVIR Endovasc
Hayakawa N   +8 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy